Fmr LLC Inmune Bio, Inc. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,973 shares of INMB stock, worth $21,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,973

Previous 1,629 82.5%

Holding current value

$21,435

Previous $7,000 228.57%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$4.93 - $10.48 $6,625 - $14,085	1,344 Added 82.5%	2,973 $23,000
Q4 2024 Feb 13, 2025	BUY	$4.4 - $6.43 $902 - $1,318	205 Added 14.4%	1,629 $7,000
Q3 2024 Nov 13, 2024	BUY	$4.86 - $9.86 $6,507 - $13,202	1,339 Added 1575.29%	1,424 $7,000
Q2 2024 Aug 13, 2024	SELL	$7.15 - $11.84 $3,575 - $5,920	-500 Reduced 85.47%	85 $0
Q1 2024 May 13, 2024	BUY	$10.53 - $14.01 $5,265 - $7,005	500 Added 588.24%	585 $6,000
Q2 2023 Aug 11, 2023	SELL	$6.5 - $10.09 $45 - $70	-7 Reduced 7.61%	85 $0
Q1 2023 May 11, 2023	BUY	$6.01 - $10.18 $498 - $844	83 Added 922.22%	92 $0
Q4 2022 Feb 13, 2023	BUY	$6.13 - $7.96 $55 - $71	9 New	9 $0

Others Institutions Holding INMB

# of Institutions

Shares Held

6.87M

Call Options Held

202K

Put Options Held

104K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $129M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account